BSEBoard Meeting2d ago · 27 Oct 2026, 07:03 pm
The Board of Directors of the Company, at its meeting held today i.e. Tuesday, October 27, 2026, has inter-alia considered and approved the Un-audited financial results for the quarter and half year ended September 30, 2026, Record date for issue of Bonus equity shares and reconstituted committees of Board.
Concord Biotech Ltd · 543960
✦ AI SummaryResults
Concord Biotech Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, and has fixed November 4, 2026 as the record date for the issue of bonus equity shares. The company has also reconstituted its committees of the board.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Board Meeting Outcome for Meeting Held Today I.E. Tuesday, October 27, 2026 - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') As Amended From Time To Time.